{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T01:48:15Z","timestamp":1790819295255,"version":"4.1.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF17OC0028866"],"award-info":[{"award-number":["NNF17OC0028866"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ajog.2019.06.050","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T11:49:56Z","timestamp":1561722596000},"page":"648.e1-648.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["In utero exposure to antibiotics and risk of congenital malformations: a population-based study"],"prefix":"10.1016","volume":"221","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0591-7187","authenticated-orcid":false,"given":"Per","family":"Damkier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise M.S.","family":"Br\u00f8nniche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan F.B.","family":"Korch-Frandsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4149-8808","authenticated-orcid":false,"given":"Anne","family":"Broe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2019.06.050_bib1","doi-asserted-by":"crossref","first-page":"2S","DOI":"10.1097\/01.AOG.0000533293.16410.58","article-title":"Effect of removal of pregnancy category on prescribing in pregnancy: a randomized trial","volume":"131","author":"Robinson","year":"2018","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.06.050_bib2","unstructured":"Pregnancy and Lactation Labeling (Drugs)\u00a0Final Rule. Available at: https:\/\/www.fda.gov\/Drugs\/DevelopmentApprovalProcess\/DevelopmentResources\/Labeling\/ucm093307.htm. Accessed February 11,\u00a02019."},{"key":"10.1016\/j.ajog.2019.06.050_bib3","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1111\/1471-0528.12806","article-title":"Increasing use of antibiotics in pregnancy during the period 2000-2010: prevalence, timing, category, and demographics","volume":"121","author":"Broe","year":"2014","journal-title":"BJOG Int J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2019.06.050_bib4","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1111\/bcp.13364","article-title":"Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study","volume":"83","author":"Muanda","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2019.06.050_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.15585\/mmwr.mm6701a4","article-title":"Antibiotics dispensed to privately insured pregnant women with urinary tract infections\u2500United States, 2014","volume":"67","author":"Ailes","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajog.2019.06.050_bib9","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1046\/j.1469-0691.2002.00368.x","article-title":"Birth outcome of 1886 pregnancies after exposure to phenoxymethylpenicillin in utero","volume":"8","author":"Dencker","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ajog.2019.06.050_bib10","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1002\/phar.1649","article-title":"A\u00a0review of antibiotic use in pregnancy","volume":"35","author":"Bookstaver","year":"2015","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ajog.2019.06.050_bib11","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1002\/bdra.23570","article-title":"Association between antibiotic use among pregnant women with urinary tract infections in the first trimester and birth defects, National Birth Defects Prevention Study 1997 to 2011","volume":"106","author":"Ailes","year":"2016","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajog.2019.06.050_bib12","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11095-018-2383-8","article-title":"Pregnancy outcomes following exposure to quinolone antibiotics\u2500a systematic-review and meta-analysis","volume":"35","author":"Ziv","year":"2018","journal-title":"Pharm Res"},{"key":"10.1016\/j.ajog.2019.06.050_bib13","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1002\/pds.2179","article-title":"Maternal use of antibiotics and the risk of orofacial clefts: a nationwide cohort study","volume":"21","author":"M\u00f8lgaard-Nielsen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2019.06.050_bib14","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/pds.3900","article-title":"Use of macrolides during pregnancy and the risk of birth defects: a population-based study","volume":"24","author":"B\u00e9rard","year":"2015","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2019.06.050_bib15","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/j.1365-2125.2012.04286.x","article-title":"Pregnancy outcome after gestational exposure to erythromycin\u2500a population-based register study from Norway","volume":"74","author":"Rom\u00f8ren","year":"2012","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2019.06.050_bib16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2165\/11630920-000000000-00000","article-title":"The outcomes of pregnancy in women exposed to the new macrolides in the first trimester: a prospective, multicentre, observational study","volume":"35","author":"Bar-Oz","year":"2012","journal-title":"Drug Saf"},{"key":"10.1016\/j.ajog.2019.06.050_bib17","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.ajog.2019.06.050_bib18","article-title":"Data resource profile: the Danish National Prescription Registry","volume":"46","author":"Potteg\u00e5rd","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ajog.2019.06.050_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s10654-018-0356-1","article-title":"The Danish Medical Birth Register","volume":"33","author":"Bliddal","year":"2018","journal-title":"Eur J Clin Epidemiol"},{"key":"10.1016\/j.ajog.2019.06.050_bib20","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ajog.2019.06.050_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.5114\/aoms.2013.39202","article-title":"Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems","volume":"11","author":"Matuszkiewicz-Rowi\u0144ska","year":"2015","journal-title":"Arch Med Sci AMS"},{"key":"10.1016\/j.ajog.2019.06.050_bib25","doi-asserted-by":"crossref","first-page":"g1908","DOI":"10.1136\/bmj.g1908","article-title":"Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study","volume":"348","author":"Lund","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2019.06.050_bib26","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00228-013-1624-3","article-title":"Fetal safety of erythromycin. An update of Swedish data","volume":"70","author":"K\u00e4ll\u00e9n","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2019.06.050_bib29","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1080\/14767050500439657","article-title":"Fetal outcome following roxithromycin exposure in early pregnancy","volume":"19","author":"Chun","year":"2006","journal-title":"J\u00a0Matern-Fetal Neonatal Med"},{"key":"10.1016\/j.ajog.2019.06.050_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1365-3016.2008.00978.x","article-title":"Antibiotics potentially used in response to bioterrorism and the risk of major congenital malformations","volume":"23","author":"Cooper","year":"2009","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/j.ajog.2019.06.050_bib31","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/00365540410021072a","article-title":"Pivmecillinam and adverse birth and neonatal outcomes: a population-based cohort study","volume":"36","author":"Vinther Skriver","year":"2004","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ajog.2019.06.050_bib32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.reprotox.2019.02.002","article-title":"Pregnancy outcomes following quinolone and fluoroquinolone exposure during pregnancy: a systematic review and meta-analysis","volume":"85","author":"Acar","year":"2019","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ajog.2019.06.050_bib33","doi-asserted-by":"crossref","first-page":"4392","DOI":"10.1128\/AAC.02413-14","article-title":"Observational cohort study of pregnancy outcome after first-trimester exposure to fluoroquinolones","volume":"58","author":"Padberg","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.ajog.2019.06.050_bib34","first-page":"978","article-title":"Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study","volume":"163","author":"Crider","year":"2009","journal-title":"Arch\u00a0Pediatr Adolesc Med"},{"key":"10.1016\/j.ajog.2019.06.050_bib35","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0890-6238(03)00012-1","article-title":"Maternal drug use in early pregnancy and infant cardiovascular defect","volume":"17","author":"K\u00e4ll\u00e9n","year":"2003","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ajog.2019.06.050_bib36","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1701-2163(15)30337-6","article-title":"Exposure to nitrofurantoin during early pregnancy and congenital malformations: a systematic review and meta-analysis","volume":"37","author":"Goldberg","year":"2015","journal-title":"J\u00a0Obstet Gynaecol Can JOGC"},{"key":"10.1016\/j.ajog.2019.06.050_bib37","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1097\/AOG.0b013e31827c5f88","article-title":"Neonatal outcomes after gestational exposure to nitrofurantoin","volume":"121","author":"Nordeng","year":"2013","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2019.06.050_bib38","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1002\/jcph.139","article-title":"Exposure to nitrofurantoin during the first trimester of pregnancy and the risk for major malformations","volume":"53","author":"Goldberg","year":"2013","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.ajog.2019.06.050_bib39","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/pds.3919","article-title":"Trimethoprim-sulfonamide use during the first trimester of pregnancy and the risk of congenital anomalies","volume":"25","author":"Hansen","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2019.06.050_bib40","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1517\/14740338.2016.1133584","article-title":"Revisiting doxycycline in pregnancy and early childhood\u2500time to rebuild its reputation?","volume":"15","author":"Cross","year":"2016","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/j.ajog.2019.06.050_bib42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s40471-014-0028-y","article-title":"Challenges in studying modifiable risk factors for birth defects","volume":"2","author":"Tinker","year":"2015","journal-title":"Curr Epidemiol Rep"},{"key":"10.1016\/j.ajog.2019.06.050_bib43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/tera.1420450206","article-title":"The interaction between dysmorphology and epidemiology: methodologic issues of lumping and splitting","volume":"45","author":"Khoury","year":"1992","journal-title":"Teratology"},{"key":"10.1016\/j.ajog.2019.06.050_bib44","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1002\/bdra.20606","article-title":"Big risks in small groups: the difference between epidemiology and counselling","volume":"85","author":"Friedman","year":"2009","journal-title":"Birt Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajog.2019.06.050_bib45","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1741-4520.2005.00062.x","article-title":"Methodological issues in the epidemiological study of the teratogenicity of drugs","volume":"45","author":"K\u00e4ll\u00e9n","year":"2005","journal-title":"Congenit Anom"},{"key":"10.1016\/j.ajog.2019.06.050_bib46","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1002\/pds.4411","article-title":"Agreement between paternal self-reported medication use and records from a national prescription database","volume":"27","author":"Cohen","year":"2018","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.ajog.2019.06.050_bib47","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/bdra.22888","article-title":"Agreement between self-report and prescription data in medical records for pregnant women","volume":"94","author":"Sarangarm","year":"2012","journal-title":"Birt Defects Res A Clin Mol Teratol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293781930883X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S000293781930883X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:26:13Z","timestamp":1757589973000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S000293781930883X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S000293781930883X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2019.06.050","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.736111254.793571199","asserted-by":"object"}]},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"In utero exposure to antibiotics and risk of congenital malformations: a population-based study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2019.06.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}